| # | Title | Journal | Year | Citations |
|---|
| 1 | The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML | Blood | 2011 | 205 |
| 2 | Comparison of the pharmacokinetics and pharmacodynamics of S‐1 between Caucasian and East Asian patients | Cancer Science | 2011 | 123 |
| 3 | Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies | Journal of Clinical Oncology | 2009 | 87 |
| 4 | Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer | Clinical Cancer Research | 2009 | 83 |
| 5 | The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer | Journal of Immunology | 2013 | 79 |
| 6 | Pharmacogenetics in Breast Cancer Therapy | Clinical Cancer Research | 2008 | 76 |
| 7 | Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial | Journal of Clinical Oncology | 2020 | 56 |
| 8 | Accumulation of CD11c+CD163+ Adipose Tissue Macrophages through Upregulation of Intracellular 11β-HSD1 in Human Obesity | Journal of Immunology | 2016 | 46 |
| 9 | Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer | International Journal of Cancer | 2014 | 44 |
| 10 | Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility | Journal of Gastroenterology | 2016 | 32 |
| 11 | Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan | Gastric Cancer | 2017 | 28 |
| 12 | Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress | Cancer Immunology, Immunotherapy | 2017 | 26 |
| 13 | Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib | Journal of Cancer | 2018 | 25 |
| 14 | Inhibition of mitogen‐activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD‐L1‐upregulation in contrast to interferon‐γ treatment | Cancer Science | 2014 | 24 |
| 15 | Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group | Annals of Oncology | 2020 | 20 |
| 16 | Potential Therapeutic Significance of HER-Family in Esophageal Squamous Cell Carcinoma | Annals of Thoracic and Cardiovascular Surgery | 2012 | 14 |
| 17 | Implication of Highly Cytotoxic Natural Killer Cells for Esophageal Squamous Cell Carcinoma Treatment | Journal of Immunotherapy | 2018 | 12 |
| 18 | Neutralizing Anti-Interferon-Gamma Autoantibody Levels May Not Correlate With Clinical Course of Disease | Clinical Infectious Diseases | 2016 | 10 |
| 19 | Infiltrative pattern of metastatic invasive lobular breast carcinoma in the abdomen: a pictorial review | Insights Into Imaging | 2021 | 6 |
| 20 | The topography of DNA methylation in the non‐neoplastic colonic mucosa surrounding colorectal cancers | Molecular Carcinogenesis | 2014 | 5 |
| 21 | P-098: Super-enhancer-driven PPP1R15B as an oncogenic and potential therapeutic target in Multiple Myeloma | Clinical Lymphoma, Myeloma and Leukemia | 2021 | 0 |
